Ischemic Optic Neuropathies 2011
DOI: 10.1007/978-3-642-11852-4_17
|View full text |Cite
|
Sign up to set email alerts
|

Management of Non-arteritic Anterior Ischemic Optic Neuropathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
0
2

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(9 citation statements)
references
References 87 publications
0
7
0
2
Order By: Relevance
“…Therefore, different treatment modalities have been suggested based on presumed pathogenic mechanisms 1 4 5 10 21. Other than systemic steroids, none of the proposed treatments have been shown to be beneficial in adequately large patient populations 5.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Therefore, different treatment modalities have been suggested based on presumed pathogenic mechanisms 1 4 5 10 21. Other than systemic steroids, none of the proposed treatments have been shown to be beneficial in adequately large patient populations 5.…”
Section: Discussionmentioning
confidence: 99%
“…Although the exact pathogenesis of NAION is not known, predisposing factors include constriction of neuronal tissue in small cupless discs (disc at risk), arterial hypertension, arteriosclerosis and diabetes mellitus 1 2. One theory points to nocturnal arterial hypotension causing ischaemia and resultant swelling of the axons, and thus increased pressure on the neuronal tissue confined within the tight borders of the posterior scleral outlet.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Small cup-to-disc ratio or absence of excavation and optic disc drusen are ocular risk factors associated with AION. 13,14 Arterial hypertension, nocturnal arterial hypotension, diabetes mellitus, ischemic heart disease, and other cardiovascular disorders, hyperlipidemia, atherosclerosis, and arteriosclerosis are considered systemic risk factors. 14,15 On the other hand, all published cases of perioperative AION have affected both eyes, often occurring in otherwise healthy patients; it is attributed to a combination of hypovolemia, hemodilution, systemic hypotension, anemia, prone position, and pre-existing cardiovascular disease.…”
Section: Discussionmentioning
confidence: 99%
“…Kaderli et al [35], in four eyes, reported visual acuity improvement, but without any improvement in visual fields. However, the study of Kaderli et al [35] has some notable flaws which are discussed in detail elsewhere [19]. For example: (a) their study is based on only four eyes, (b) large natural history studies [28,40] have shown spontaneous visual acuity improvement in 41% of eyes with NA-AION, and (c) more importantly, all the eyes in the study by Kaderli et al [35] showed no improvement in visual fields and all had altitudinal visual field defects.…”
Section: Use Of Intravitreal Triamcinolone Acetonide For Treatment Ofmentioning
confidence: 99%